| Followers | 2565 |
| Posts | 300014 |
| Boards Moderated | 29 |
| Alias Born | 04/12/2001 |
Thursday, March 11, 2021 4:47:03 PM
The SEC is literally convoluting the system so much that it’s a mockery.
While they have their faults, they're not doing that. The SEC doesn't do Caveat Emptor designations; that's an OTC Markets thing. OTC Markets is not a regulator.
They stated companies had until June or September to get current, then they go on a suspension frenzy.
They didn't say that. The amendments to Rule 15c2-11 became effective on 28 December 2020:
https://www.sec.gov/rules/final.shtml
There is what the SEC calls a transition period, lasting from the end of December 2020 till the end of September 2021. Issuers unable to comply immediately are encouraged to contact the SEC and request relief from compliance.It's always a good idea to keep the regulators in the loop.
https://www.sec.gov/rules/final/2020/33-10842.pdf
While they have their faults, they're not doing that. The SEC doesn't do Caveat Emptor designations; that's an OTC Markets thing. OTC Markets is not a regulator.
They stated companies had until June or September to get current, then they go on a suspension frenzy.
They didn't say that. The amendments to Rule 15c2-11 became effective on 28 December 2020:
https://www.sec.gov/rules/final.shtml
There is what the SEC calls a transition period, lasting from the end of December 2020 till the end of September 2021. Issuers unable to comply immediately are encouraged to contact the SEC and request relief from compliance.It's always a good idea to keep the regulators in the loop.
https://www.sec.gov/rules/final/2020/33-10842.pdf
Join the InvestorsHub Community
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
